Join Proteona at the Global Cluster Partnering (GCP) – Healthcare
Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology
Meet Proteona at the Global Cluster Partnering (GCP) – Healthcare event, taking place virtually from the 26th to the 27th of August 2020.
Proteona CEO Dr. Andreas Schmidt will be available during the event to share the latest progress at Proteona and the upcoming partnering and investment opportunities.
The GCP – Health care event is co-organized renowned European and international biotech networks including Ascrion, BIO Deutschland, and BioRN. It attracts an international audience from healthcare-related industries such as biopharma, medtech, and biotech.
Secure your meeting slot with Proteona now!
For media queries, please contact:
Dr Andreas Schmidt
Proteona is a precision medicine company in Singapore, Germany, and the US that is pioneering the use of single cell multi-omics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona enables pharmaceutical companies, biotech partners, and clinicians to integrate single cell level precision into their clinical projects. Proteona continues to develop comprehensive, disease-specific single cell databases combining gene expression, protein expression, and mutation information derived from each individual cells as well as drug response data for each sample. Proteona has been selected as a “One to Watch” by Nature Research Spinoff Award and a Winner of Falling Walls Ventures Breakthrough of the Year 2020. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR).